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Abstract
Background: Research and evidence can have an impact on policy and practice, resulting in positive outcomes.
However, research translation is a complex, dynamic and non-linear process. Although universities in Africa play a
major role in generating research evidence, their strategic approaches to influence health policies and decision
making are weak. This study was conducted with the aim of understanding the process of translating research into
policy in order to guide the strategic direction of Makerere University College of Health Sciences (MakCHS) and
similar institutions in their quest to influence health outcomes nationally and globally.
Methods: A case study approach using 30 in-depth interviews with stakeholders involved in two HIV prevention
research project was purposively selected. The study sought to analyze the research-to-policy discourses for the
prevention of mother-to-child transmission (PMTCT) and safe male circumcision (SMC). The analysis sought to
identify entry points, strengths and challenges for research-to-policy processes by interviewing three major groups
of stakeholders in Uganda – researchers (8), policy makers (12) and media practitioners (12).
Results: Among the factors that facilitated PMTCT policy uptake and continued implementation were: shared platforms
for learning and decision making among stakeholders, implementation pilots to assess feasibility of intervention, the
emerging of agencies to undertake operations research and the high visibility of policy benefits to child survival. In
contrast, SMC policy processes were stalled for over two years after the findings of the Uganda study was made public.
Among other factors, policy makers demanded additional research to assess implementation feasibility of SMC within
ordinary health system context. High level leaders also publicly contested the SMC evidence and the underlying values
and messages – a situation that reduced the coalition of policy champions.
Conclusions: This study shows that effective translation of PMTCT and SMC research results demanded a “360
degree” approach to assembling additional evidence to inform the implementation feasibility for these two HIV
prevention interventions. MakCHS and similar institutions should prioritize implementation research to guide the
policy processes about the feasibility of implementing new and effective innovations (e.g. PMTCT or SMC) at a
large scale in contexts that may be different from the research environments.
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Uganda has a heavy burden of disease as reflected in
poor health indicators. For example, the under five mor-
tality was 137 deaths per 1,000 live births in the years
2001-2005, and the maternal mortality ratio was 435
deaths per 100,000 live births in 2005 [1]. Even though
there are some positive trends in several health out-
comes, Uganda is not on track to meet Millennium
Development Goals (MDGs) 4, 5 and 6. The Govern-
ment of Uganda is committed to achieving the MDGs,
which are reflected in National Development Plan,
National Health Policy 2010 to 2020, and Health Sector
Strategic and Investment Plan (HSSIP). The HSSIP calls
for universal delivery of the Uganda National Minimum
Health Care Package captured under the four clusters
namely: environmental health, health promotion, disease
control and community health initiatives; maternal and
child health; prevention, management and control of
communicable diseases; and prevention, management
and control of non-communicable diseases [2].
A vital entry point to meeting the MDGs is to focus
on health systems performance. Effective health systems
research and the translation of research into actions are
central to enhancing this performance. However, what
remains unknown is which strategies actually work in
translating such research into policy. Many national
health systems (including Uganda) are at a critical junc-
ture – the reform and re-orientation of these health sys-
tems requires innovative thinking and a concerted effort
to use existing evidence. However, a large proportion of
health systems research to-date is unfortunately sepa-
rated from decision making processes [3,4]. Globally, for
knowledge generated from research to be beneficial it
should be shared, communicated and translated into
policy, practice and/or action [5]. The World Health
Organization (WHO) defines knowledge translation as
“the synthesis, exchange and application of knowledge by
relevant stakeholders to accelerate the benefits of global
and local innovation in strengthening health systems and
improving people’sh e a l t h ” [6]. Research and evidence
can have an impact on policy and practice, resulting in
positive outcomes. However, knowledge translation is a
complex, dynamic and non-linear process that is gener-
ally slow. Slow knowledge translation can result in inap-
propriate decision-making and care to the population
[5,7]. Strategies and processes to increase the use of
research in decision making are poorly understood and
require creativity, intellectual rigor, skills and organiza-
t i o n a ls a v v ya n de n d u r a n c e[ 7 ] .As t u d yb yL a v i sf o u n d
that the research-to-policy gaps were related to a myriad
of factors that policymakers have to consider, such as the
value attached to research evidence in decision making,
and to weak relevance of the research evidence and the
concerns of policy makers at a point in time [8].
The translation of evidence to policy and improved
practice in low and middle income countries (LMIC) has
the potential to reduce the gap in morbidity and mortality
for disadvantaged populations. For example, access to and
utilization of treatments and technology that improves
diagnostic accuracy can enhance interventions for rural
and urban poor [9,5]. A recent descriptive study on knowl-
edge translation policies and activities of national and
international health research funders working in LMIC
indicated that there was increasing interest by agencies to
engage in knowledge translation activities. However, bar-
riers such as a lack of a common terminology in knowl-
edge translation, limited consideration of which evidence
needs translation, and how to best tailor the evidence and
the approaches to reach different stakeholders existed. In
Africa, it is particularly vital that evidence of effective stra-
tegies yielded through research is used to inform policy so
that the limited resources available can be put to good
use. However, little documentation exists as to what extent
this is being done in African countries like Uganda and
what processes might facilitate or hinder the bridging of
this evidence to policy gap [9-11].
Successful translation of research evidence to policies
and programs has taken place in Uganda in the last 5
to10 years. Most of these have arisen from research
undertaken in Uganda. For example, the Ministry of
Health adopted artemisinin-based combination therapy
in the treatment of malaria after studies conducted
within the country showed marked resistance to the
regimen usually recommended by the Ministry [12-15].
Many research activities in which Uganda participated
have also led to global level policy and practice recom-
mendations. Some of the examples include the antire-
troviral therapy http://www.medterms.com/script/main/
art.asp?articlekey=14370 (ART), preventing mother to
child transmission (PMTCT) [16,17] and safe male cir-
cumcision in HIV prevention [18]. Integrated manage-
ment of childhood illness and home-based management
of fevers, and Tuberculosis - directly observed treatment
strategies have related policies which were adopted by
WHO after successful pilot testing in countries includ-
ing Uganda [19]. In a yet another recent example, rou-
tine counseling and testing was quickly adopted as
policy to in-patient admissions after research demon-
strated overwhelming benefits for prevention and treat-
ment of HIV [20,21].
Overall, this study was conducted with the aim of
understanding the process of translating research into
policy in order to improve health outcomes related to
national health priorities in Uganda. The first specific
aim of this study was to learn from the national pro-
cesses for translating research for PMTCT and safe
male circumcision (SMC). Both research projects were
conducted in Uganda and at the time of this study,
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policy and programs compared to SMC. Although SMC
research results had been disseminated since 2007, there
was little progress in the policy processes by 2009 when
this study was launched. The second specific aim of this
study was to explore strategies for academic institutions
like Makerere University College of Health Sciences
(MakCHS) to influence the translation of research into
policy and practice. This is a prerequisite for such insti-
tutions to influence health outcomes. Given the Ugan-
dan context, two research questions were addressed: 1)
Why and how did PMTCT and SMC differ in terms of
research-to-policy translation? and 2) What values,
interests and criteria are used by key stakeholders in
sharing, amplifying and using research evidence? The
analysis sought to identify the entry points, strengths,
and challenges for advancing the use of evidence into
policy development processes in the health sector of
Uganda. Such evidence is critical for health training
institutions like MakCHS to adopt effective strategies to
influence national health development [22].
Methods
This study was informed by a number of frameworks
linking the research-policy interface. One such concep-
tual framework describes key elements as: processes of
research generation and decision-making; the stake-
holders; the products; the mediators; and the context
[23]. Mediators, individuals or institutions who foster
linkages between different stakeholders are described as
the most crucial component of the framework that
encourages strong research-policy linkages [23]. More
recent efforts at framework construction have focused
on country-level assessment of linkages between
research and action [8]. The proposed framework has
four elements: 1) general climate; 2) research produc-
tion; 3) a mix of push and pull factors; and 4) evaluation
approaches. The critical role of a wide range of stake-
holders, such as researchers, policymakers, funders and
consumers and advocacy groups is also acknowledged in
linking research to action. Another recent framework
exploring health systems research and its influence on
policy processes in low-income countries articulates
four “streams of influence” on the research-policy inter-
face: development contexts; stakeholders; accountabil-
ities; and processes [24]. For instance the development
context encourages the examination of capabilities of
the health system to support priority research as well as
acting on evidence when available. In developing coun-
try context the external stakeholders – experts and
donors may form part of the influence network. In this
paper we used the range of variables espoused in these
frameworks to help frame the analysis around the major
influences of research on health policy in Uganda.
We employed two case studies to draw lessons on how
to research influences policy developments in Uganda
(Table 1). The PMTCT and SMC were selected based on
a consultation workshop in early 2009 in Kampala in
which researchers, policy makers and donors partici-
pated. A comparison of both cases demonstrates the
similarities and differences around HIV prevention in
Uganda (Table 1). For both these interventions, a
national level network of stakeholders – researchers, pol-
icymakers and the media - were identified as critical to
the generation, utilization and amplification of evidence
respectively. These three categories of stakeholders form
the groups that were interviewed in this study. Although
the general public is a vital stakeholder in the research-
Table 1 Comparison of case studies-PMTCT and SMC–in Uganda
Concepts PMTCT SMC
Status of policy PMTCT policy adopted in 2001 SMC policy formulation in progress (2009)
Stage in R-2-P
processes in 2009
Policy implementation stage Analysis of policy feasibility and agenda setting
Type of research
evidence generated
Implementation level evidence of effectiveness Proof of concept for SMC – multi-country clinical trials (Rakia,
Kisumu and Orange Farm)
Methods used for
generating evidence
Large cohorts of program beneficiaries, i.e. children
and mothers enrolled in PMTCT programs
Multi-country randomized clinical trial; country level acceptability
surveys; service availability services
Objectives of the
researchers’ policy
engagement
To improve the national policy implementation
approaches; Changes to cost-effective approaches
To establish global policy guidelines; establish national SMC
programs; mobilize funds for SMC programs
Influential decision-
making audiences
National technical level decision makers (MOH WHO,
UNAIDS, UNICEF and EGPAF); Makerere College of
Health Sciences
Mostly global multilateral agencies e.g. WHO, UNAIDS, Gates
Foundation and NIH; MOH and political leaders i.e. president’s
opinion about SMC
Secondary audiences Implementers of PMTCT programs; Funding agencies
of PMCTC programs; WHO and UNAIDS (validation of
their guidelines)
National level leaders, technical decision makers, media
practitioners; general public; HIV funding agencies; Implementers
(e.g. hospital managers and surgeons)
Methods for engaging
national level decision
makers
Researchers are integrated into decision-making fora e.
g. PMTCT National Advisory Committee and
committees
Transactional or “arms-length” engagement methods by
researchers e.g. occasional dissemination events, policy briefings
and mass media.
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not allow us to pursue this stakeholder group.
This was a qualitative study where in-depth interviews
(IDI) were conducted with key stakeholders including
policy makers, technical officers, funders, researchers,
a n dp r i n ta n dm e d i aj o u r n a l i s t s( t e l e v i s i o n ,p r i n ta n d
radio). The purpose of the in-depth interviews was to
provide an understanding of the research to policy pro-
cess, with a specific focus on PMTCT and SMC. We
conducted 30 in-depth interviews with researchers (8),
policy makers (12), and media journalists (10). The
main selection criteria for researchers and policy makers
was their involvement in the decision making around
the PMTCT and or SMC process at any time since the
year 2000. For the media, they were selected mainly
b e c a u s et h e yw e r ei n v o l v e di nh e a l t hr e l a t e dr e p o r t i n g
on a regular basis in Uganda.
A purposeful sampling frame for the in-depth inter-
views was constructed in consultation with peers in the
P M T C Ta n dS M Cd o m a i na sw e l la st h o s ew h oh a v e
worked in health related policies in Uganda. First, brain-
storming discussions were conducted with a reference
group familiar with policy research to generate the
initial sampling frame. Then, during interviews, snowball
sampling strategy was applied and after each in-depth
interview was conducted, the interviewee was requested
to identify one to two other possible respondents that
they deemed relevant to the study. The research team
then updated the list of interviewees from which the
respondents were drawn.
Interviews were conducted in English and audio
recorded (with consent) and transcribed by the research
team thereafter. In a few cases, individual were not will-
ing to be audio recorded. In such circumstances, we
took hand written notes of the interviews which were
later expanded. During data collection phase de-briefing
meetings were held with research team members at the
end of each day to ensure good quality data and share
new and emerging issues. All interviewers were trained
in qualitative interview techniques. The interview tool
was pilot tested with volunteer colleagues within
MakCHS. Transcription was completed within 48 hours
following interview.
The initial step for analysis was to read through all the
interview transcripts several times while making notes in
the transcript. All investigators participated in this pro-
cess. Analysis was a mixture of Manifest and Latent
content analysis techniques. At first manifest content
analysis was done in reference to the study conceptual
framework. This type of analysis technique allows one
to explore what the text says, deals with the content
aspect and describes the visible, obvious components.
For a closer look of underlying meanings (Latent) con-
tent analysis was done and hidden meaning of text was
brought forth [25]. Data was therefore condensed with-
out losing quality. Open coding was done and codes
were categorized and then themes identified as stipu-
lated by Graneheim and Lundman [25].
This study was approved by the Institutional Review
Boards (Ethics Committees) at Makerere University-
School of Public Health, Uganda and Johns Hopkins
Bloomberg School of Public Health, USA. Permission to
conduct the study was also granted by the Uganda
National Council of Science and Technology. Verbal
consent was solicited from each individual identified as
a respondent for the in-depth interview prior to starting
the interview.
Results
This study was conducted among thirty stakeholders
(8 researchers, 12 policy makers, 10 media journalists).
The respondents were experienced in their work and
held influential positions (Table 2). In addition, they had
been in their positions of work for a period not less
than 5 years. Majority of researchers had done clinical
trials, got funding from UN and multilateral agencies,
and their primary audiences were the funding agencies.
The majority of media practitioners were news editors
with more than 5 years of experience. The data from
these interviews was collated under three domains of
interest; ‘Lessons learnt from PMTCT’, ‘Lessons Learnt
from SMC’ and ‘Evidence that Drives Policy’. There are
several themes (categories) and sub-themes that
emerged under each domain based on content analysis
(Table 3).
Lessons from PMTCT program
The PMTCT policy was adopted in 2001 in Uganda
after a pilot study covering three districts in 2000. By
the time of this research, PMTCT policy guidelines had
undergone several revisions based on the evidence aris-
ing from several research agencies that were implement-
ing the program, as well as research around operational
challenges (Table 1). Factors that stand out as facilitat-
ing the PMTCT policy uptake and continued use of
implementation research to improve programs are
grouped under the following categories below: ‘shared
platforms for learning and decision making’, ‘pilot to
Table 2 Characteristics of the study respondents in
Uganda (n=30)
Type of research Type of policy makers Type of media
Health Policy Donors Print
Epidemiology Politicians Radio
Case studies Technical/Program Manager* Television*
Clinical Trials*
*denotes majority of respondents’ expertise.
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to undertake operations research’ and ‘ visibility of the
benefits’.
Shared platform for learning and decision making
Under the leadership of UNICEF and the Ministry of
Health (MOH), the research scientists in Uganda
together with the in-country officials of international
agencies like Elizabeth Glaser Pediatric AIDS Founda-
tion, United states Agency for International Develop-
ment, UNAIDS and World Health Organization formed
a PMTCT National Advisory Committee to oversee the
national implementation of the findings from the Nivera-
pine study. The PMTCT National Advisory Committee
was chaired by the principle research scientist that car-
ried out the Niverapine study and was the main decision
making body for developing policy guidelines. One of the
authors was also a member of this PMTCT National
Advisory Committee and provided expertise for costing
and cost-effectiveness of the pilot intervention. Both
implementers and research agencies benefited from shar-
ing the decision space (PMTCT committee) and learning
together with their colleagues from financing agencies.
Table 3 Example of the content analysis process for the study
Codes Categories Theme
-PMTCT National Advisory Committee was chaired by the scientist that carried out the
Niverapine study
-The PMTCT National Advisory Committee was the main decision-making body
-The first author was also a member of this PMTCT National Advisory Committee
-Both implementers and research agencies benefited from sharing the decision space
Shared platforms for learning and
decision making
Lessons learnt
from PMTCT
-The PMTCT National Advisory Committee commissioned a pilot study to learn about the
operations feasibility
-A national pilot was established to examine the feasibility of implementing PMTCT
-Pilots aimed to assess how integration of PMTCT into ANC might affect the acceptability
Pilots to assess feasibility of
Interventions
-History of shared decision-making platform
-Sustained collaboration with research agencies like MUJHU, JCRC and PIDC.
-Integration of technocrats, basic and operations research scientists along with funding
agencies interested
-PMTCT National Advisory Committee used research to quickly adjust the guidelines to
stop single dose Niverapine when it failed
Evolution of Agencies to
undertake Operational research
-700,000 pregnant women are screened annually
-Many babies remained HIV negative
-The faces of these babies and smiles of grateful mothers are common
-Beneficiaries often in media reports
-It is harder now to find HIV positive babies
-When people see this change they are more willing to implement the policy
Visibility of the Benefits of PMTCT
-SMC policy audiences were primarily global, the nature of policy decision had tight
connections to global agencies like WHO, UNAIDS and NIH.
-SMC research in Uganda, Kenya and South Africa was funded by global stakeholders
-WHO called us, we shared our results with other experts
Global vis-à-vis National Policy
Process
Lessons learnt
from SMC
-The demand for a series of addition research evidence
-MoH discuss translation of SMC evidence into policy
-Feasibility questions emerged
-We are also looking at cultural sensitivity
Demand for feasibility research
-SMC benefits happen when a large number has undertaken the service
-Benefits are difficult to visualize by the policymakers
-Researchers envision complexity of this process
-Can existing services to shoulder circumcision
Less visible evidence for SMC
-Sharp differences in values prevail among researchers, policy makers & media
-Contribution to science, career development… member of big scientific network
-Driven by the need to find simpler and cost-effective solution
-Motivated by the duty to inform the public
-Maintain the interest of the audience
Incentives and values Evidence that
drives policy
The main rationale for researcher-policy maker communication was:
-PM driven by the need to share positive findings from research
-Researchers’ attitudes were not favorable to active engagement and dissemination
-Delays in dissemination process “dancing in the corridors”
-Media prefer evidence from a locally recognized expert
Communication among groups
-Evidence judged as useful for decision making
-We want randomized controlled trials
-Decision makers assigned more weight to research that addresses operational problems
-Emphasizes the number of the population affected
Strengths of evidence
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tion research and development of PMTCT programs. As
an example one policy maker remarked that:
“When a study is presented here, we subject the findings
to the PMTCT National Advisory Committee which has
many researchers from academia, partners [donors] and
our team [Ministry of Health]. For example, in November
2008, JCRC presented their research finding. The PMTCT
advisory committee took up that finding. In January 2009
we wrote a circular to all the implementing facilities to
stop using single doses Niverapine.” (Policy Maker-MOH)
Pilot to assess feasibility of the intervention
Respondents revealed that early on, the PMTCT
National Advisory Committee commissioned a pilot
study in three districts to learn about the operational
issues and feasibility of implementing the intervention.
With support of UNICEF, the feasibility of implement-
ing PMTCT within the antenatal care clinics (ANC),
consequent acceptability of PMTCT and ANC service
utilizations were studied [26,27]. As expressed by the
MOH official, the PMTCT policy and guidelines were
adopted following favorable pilot results:
“… the Ministry of health and government said can we
take this [PMTCT] up? So, in 2000 and before the program
was rolled out [...] pilot studies were conducted in 3 dis-
tricts and 5 health facilities. The aim was to see how best
to roll out PMTCT. Do we need to have specific clinics for
PMTCT? Can we integrate it into the existing workforce?
Will stigma of HIV testing chase away the mothers? So
they did a pilot for 1 year in 2000 and showed that we can
integrate the PMTCT program into the existing services.
This never scared the mothers from antenatal services. So
with that information in mind, the first PMTCT policy was
written in 2001” (Policy Maker-MOH).
Evolution of agencies to undertake operations research
Data also revealed that given the history of a shared
decision-making platform (PMTCT National Advisory
Committee) the PMTCT program had a sustained colla-
boration with research institutions like Makerere Uni-
versity-Johns Hopkins University program, Joint Clinical
Research Center, and Paediatric Infectious Disease
Clinic. These agencies specialized in PMTCT operations
research and had large cohorts of program beneficiaries
that made the generation of operational evidence easy
and credible. The integration of technocrats, basic and
operational research scientists, along with funding agen-
cies interested in PMTCT programs made sharing of
implementation research evidence and decision-making
more efficient. For example, when operations research
showed that mothers of babies exposed at birth to single
dose Niverapine were at increased risk developing resis-
tance to the drug, the PMTCT National Advisory Com-
mittee quickly adjusted the guidelines to stop single
dose Niverapine for PMTCT.
The emergency of specialized PMTCT operations
research agencies also helped to reduce the gap between
the knowledge demand for policy implementation and
the evidence generated from research activities.
“Our organization has supported us to attend WHO
meetings as technical advisors, also many of us here
[researchers] participate on the PMTCT National Advi-
sory Committees, the national antiretroviral treatment
committees and national pediatric and adult guideline
committee” (Research Scientist)
In the same vein, another respondent echoed that:
“Currently we are doing a study to determine if six
weeks versus six months of infant prophylaxis with Nevir-
a p i n eh a v ea n yd i f f e r e n c ei nb e n e f i t s[ …]b e c a u s ew e
know that if it takes six weeks, infant Nevirapine is easier
to implement than the six months.”(Research Scientist)
Visibility of the benefits from PMTCT program
Our interviews revealed that there was high visibility of
PMTCT program and its indicators were well known.
For example, indicators demonstrating that over 700,000
pregnant women are screened annually and over 80 per-
cent of those found positive were getting enrolled into
PMTCT programs [28]. Research programs with cohorts
of PMTCT beneficiaries were mentioned to demonstrate
that many babies remained HIV negative, and the faces
of these babies and smiles of grateful mothers are com-
mon in the media reports. A typical quote from a
researcher demonstrates this view:
“… it is harder now to find HIV positive babies because
we have shown that PMTCT has reduced the number of
babies who get infected. Maybe not as big as we would
want, but there is truly a change. When people see this
change they are more willing to implement the policy,
strengthen it and invest resources.” (Research Scientist,)
This view was in agreement with policy makers who
affirmed that the contribution of PMTCT results and
the positive outcomes are tools for advocacy in resource
mobilization.
“We know that PMTCT saves the child from getting
HIV and therefore saves the future generation. We have
used this to advocate for the PMTCT program and the
stakeholders get excited about that. […]One child saved
from the program is worth the costs of the program.”
(Policy maker)
Despite the high benefits of PMTCT, major imple-
mentation challenges limit the scale-up of the programs
beyond the 50 percent coverage. Some elements of the
program remain unimplemented due to constraints in
the health and community systems. These challenges
have attracted more implementation research to fine
tune the policy and practices. From this perspective
some respondents suggested that getting to a policy is
not sufficient to guarantee its benefits to the commu-
nities or among beneficiaries:
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program scale-up once there is a policy. We have had
the policy for PMTCT but little program scale up. Why
has it not moved? Because there are also challenges in
implementation that need implementation research.”
(Research Scientist-)
Lessons from SMC program
In contrast to PMTCT that took one year to become
national policy, SMC policy processes were in an infan-
tile stage at the time of this research despite two years
of vigorous national and international dissemination of
the SMC research. The major evidence driving the SMC
policy process was from a unique research setting but
with the strongest impact due to rigorous methodology
and multi-site concordance of results [18]. SMC
research scientists and policy makers interviewed in this
study showed that the progresses of policy translation
were much slower. In this domain analysis indicated
that three major drivers of the policy process could be
identified under the following categories: ‘global vis-à-vis
national policy process’, ‘demand for feasibility research’
and ‘less visible evidence from SMC’.
Global vis-à-vis national policy processes
For SMC, targeted policy audiences were primarily glo-
bal agencies that influence HIV care and prevention
policies around the world. Although Ugandan stake-
holders like MOH and media were engaged during the
research processes, the nature of policy decision and
especially financial allocation for SMC and HIV pro-
grams had tight connections to, and sought validation
from, normative global agencies like WHO, UNAIDS
and NIH. Research scientists involved in SMC studies
indicated that these global agencies were the primary
policy audiences and attracted more direct engagement
and dissemination of evidence. SMC research in
Uganda, Kenya and South Africa was funded by these
global stakeholders, who were also influential for trans-
national policy diffusion.
Most importantly, the financing of SMC intervention
was also perceived to arise from global or Western fund
holders like the Global Fund and USA’sP r e s i d e n t i a l
Emergency Fund for AIDS Relief (PEPFAR). Ugandan
(and other) national level stakeholders were therefore
treated as secondary audience by SMC research scien-
tists –due also to the overall architecture of multi-coun-
try studies which require a global-structure that collates
evidence from different countries and provides technical
policy recommendations to all HIV affected countries.
WHO and UNAIDS act as global-structures for SMC
research and developed policy briefs and provided tech-
nical advice to all countries to add SMC to their HIV
preventions strategies. One of the researchers vividly
explained:
“the male circumcision studies were funded by NIH
a n dW H O .W ew e r ec a l l e dt oG e n e v at oj o i nr e s e a r c h
t e a m sf r o mK e n y aa n dS o u t hA f r i c at og u i d et h ep o l i c y
development by WHO and UNAIDS. […] we also devel-
oped a dissemination strategy for the results and engaged
the (Ugandan) Ministry of Health. […] but let us face the
facts - the Ministry of Health will not proceed with male
circumcision without the funds from PEPFAR or Global
Fund. So our dissemination in Geneva had all these
agencies represented.” (Research Scientists).
Demand for feasibility research
At the time of this research, a Ugandan national SMC
taskforce had been formed comprising MOH officials,
and surgeons to advise about the implementation of the
program. A striking similarity with PMTCT policy evo-
lution was the demand for a series of additional research
studies regarding feasibility of SMC implementation. As
the Ministry of Health started to discuss the translation
of the SMC evidence into policy, feasibility questions
emerged that demanded additional operations research.
The text below from a policy maker highlights this view:
”The issue of feasibility is very important. SMC should
be simple and user friendly to our health providers
because they are the ones who are going to implement it.
[...] at the end of the day we are going to choose what is
most user friendly to health care providers. Secondly, is
the issue of acceptability to the general public. We are
also looking at cultural sensitivity. We have been imple-
menting HIV prevention strategies already - the ABC +.
So the way we are introducing circumcision must not kill
the good things which are already in HIV prevention. So
those are some of the considerations to make sure that
our SMC policy becomes more feasible and more accep-
table” (Policy Maker).
With the support of donor agencies like Family Health
International and Futures Group, studies were commis-
sioned to assess the SMC acceptability, system-level
readiness, and the potential cost-effectiveness of the
s t r a t e g y .Ap i l o tf o rS M Cw a ss e tu pi no n ed i s t r i c ti n
Uganda – Kayunga - to generate more operational evi-
dence for policy learning and translation. From this per-
spective, the strong proof-of-concept evidence from
clinical trials was not adequate for the decision makers.
The demand for additional evidence suggests that a
broader package of evidence is needed for the policy
process to advance. The evidence package needs to
incorporate feasibility assessment of adopting the new
interventions.
“I think the Ministry of Health tries to do its part but
many of the interventions from research are not cheap
and are not easy to implement, the challenge of human
resource, financial resources and also the whole issue of
scale-up. We can implement something in a small unit
but to implement it across the whole country does
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higher power beyond the Ministry”. (Research Scientist)
Less visible evidence for SMC
Unlike PMTCT, the benefits for SMC are said to accrue
after a large number of the eligible population has bene-
fited and these benefits are often less tangible for policy-
makers. Numbers and rates association with SMC were
less well known and more challenging to understand.
Communication and decision-making tools such as
mathematical modeling were being used to provide
visual aids for future impacts and benefits in HIV pre-
vention by SMC investments. One of the respondents
among the researcher scientist expressed this as a com-
plex process:
”First of all you need to do a needs assessment, you
need to do a mapping of the Health facility whether they
exist or are able to shoulder circumcision. You need to
come up with a communication strategy, you need to do
a modeling of the costs and impact of circumcision on
the HIV epidemic in Uganda. All these are needed to
support implementation of circumcision.” (Research
Scientist-)
What evidence should drive policy?
Respondents were asked about the preferred characteris-
tics and sources of evidence and their motivation and
incentives for generating, disseminating or utilizing
health related research findings. Table 4 summarizes the
nature and types of responses and reflects the contrasts
in values, rationale for sharing, use and nature of evi-
dence by the three groups of stakeholders. The data is
collated under three themes ‘Incentives and values’,
‘rationale for communication’ and ‘strength of evidence’.
Incentives and values for communicating and sharing
research results
Our data revealed some differences in the values prevail-
ing amongst researchers, decision makers and media
practitioners. The contribution to science, career devel-
opment, and being part of a large scientific network,
were some of the incentives for researchers to partici-
pate in research. The attraction of decision makers to
research was mostly driven by the need to find simpler
and cost-effective solutions that address the major bot-
tlenecks for improving the welfare of their communities.
Media practitioners were mostly motivated by the duty
to inform the public, entertain and generate debate, and
maintain the interest of the audience while generating
income and goodwill from the public. The need to gen-
erate debate was also important – usually implying that
different views, some contrary to researched evidence
are encouraged by media practitioners.
“Generating debate on major issues is the main incen-
tive. One of the stories which really gave me interna-
tional recognition, was this argument between the Global
Fund, Ministry of Health and Ministry of Finance. The
Global Fund’s view was that its money should just be
additional, - to increase health spending. The Ministry of
Finance was saying that increasing health spending
beyond a certain fixed ceiling will cause economic pro-
blems for the country. It was a very interesting debate”
(Media Practitioner-Print)
Our results show resistance to uptake of SMC due to
the nature of the intervention, as well as the underlying
values espoused by high level decision makers in the gov-
ernment. Research narratives show instances, where high
level decision makers publicly expressed views doubting
the evidence of SMC by citing popular observations of
HIV infection among circumcised individuals and com-
munities. They also worried about the misunderstanding
or impact that SMC could cause to other interventions
like condom distribution. Our findings show that once
high level policy makers had publicly expressed unsup-
portive views about the SMC evidence, other decision
makers in the lower ranks were uncomfortable to contra-
dict high authorities. In their narrative, lower ranking
policy makers worried that their job security would suffer
if they in turn championed the policy process. In this cir-
cumstance, the media and civil society in general,
assumed the role of championing the SMC process.
“Research shows that SMC has 60 percent protection
but the problem is that while other governments have
gone ahead, Uganda is not moving. Government is taking
its time over policy. It is not a priority, the leadership is
not convinced. Some top leaders say it does not work, the
ministry is saying go and popularize circumcision. So
there are contradictions but we try to advocate for it
(Media Practitioner – Print)
Rationale for communication among the three groups
The main rationale for researcher-policy maker commu-
nication was driven by the need to share positive find-
ings from research. Many researchers’ attitudes were not
favorable to active engagement in dissemination of their
findings to policy makers or the public. Instead, passive
approaches e.g. sharing of reports with decision makers
or media was preferable. Active approaches like face-to-
face meetings, on-going dissemination and advocacy
were considered as time wasting as one of the research-
ers referred to it as–“ dancing in the corridors”. Hands-
off approaches such as downloading journal publications
by policy makers were considered sufficient by many
research scientists. In contrast, decision makers were
interested in research findings that advanced their con-
temporary problems in expanding welfare programs.
Operations research findings that provided answers to
challenges like how to finance, implement and scale-up
programs like PMTCT and SMC were preferred.
Media practitioners reported that they preferred evi-
dence from a locally recognized expert as opposed to a
Ssengooba et al. BMC International Health and Human Rights 2011, 11(Suppl 1):S13
http://www.biomedcentral.com/1472-698X/11/S1/S13
Page 8 of 13journal. Their interest was to access “famous” experts that
would “put a face or voice” to the evidence. In this respect,
the media usually seek senior research scientists although
with little success and lots of frustration. Most media prac-
titioners complained that research scientists have no time
for them and use scientific jargon to communicate.
”I really would prefer to speak to the medical profes-
sionals unfortunately they tend to be press shy, generally
hard to catch…….. the majority think that giving infor-
mation to the press is a waste of their time. They don’t
trust the press. Even when they have goodwill they use a
very difficult language. The journalists get terrorized by
the medical jargon” (Media Practitioner-Print)
Criteria for judging strength of Evidence
This study revealed that the three groups of stake-
holders in this study expressed marked differences in
t h ew a yt h e yj u d g ee v i d e n c et ob eu s e f u lf o rd e c i s i o n
making, amplification, and dissemination. The research
scientists assigned high weights to evidence that comes
from cohort studies, randomized controlled trials , and
multi-site studies to assure representativeness.
“We want randomized controlled trials but some of the
observational cohort- especially the large cohorts con-
ducted over a long period of time- can give good infor-
mation on how best to manage certain conditions”
(Research Scientist).
Decision makers assigned more weight to research
that addresses operational problems they face at the
time, and did not care much about the design of the
study but focused on its relevance to the problem at
hand. Overall, decision makers expected a broader set of
evidence especially for new innovations like SMC. They
expressed demand for evidence to address the technical,
political, economic and social-cultural dimension of new
interventions like SMC. At the time of this research,
only the technical dimension of SMC was available from
the randomized controlled trials [18,29,30].
For media practitioners, the importance of evidence
was driven by the need to have several views repre-
sented to achieve a “balanced” story as well as good tim-
ing. In this process the media assigned high weights to
experts who would be available to talk about the evi-
dence and to the evidence that addressed a “hot” issue.
For television, a widely known expert was vital to build-
ing credibility for the story or evidence. The quote
below highlights how a triangulation of sources of evi-
dence was needed for a credible story to be telecast:
“W eu s es e v e r a ls o u r c e si no n es t o r y .O n es o u r c ei s
experience. Someone has been affected by a problem he is
an authority. We have experts. By experts I mean people
who are qualified in that specific area like a doctor, a
gynecologist […]. Then we have researchers with new find-
ings and publications. The other source is the policy
makers or policy implementers. We also seek people in the
system; we have to ask them – we have to confirm certain
issues with them. People with different views are also
Table 4 Preferred characteristics and sources of evidence for policy in Uganda
Concepts assessed Researchers Decision makers /funders Media and CSO
Incentives and values
for research
generation or
utilization
- Contribution to
science and public
health
- Prospects for career
development
- networking with other
experts
- Income generation
- Optimizing wellbeing of communities
- Demonstrating results & visible benefits
- Improving value for money –(cheaper and
effective)
- Simplifying interventions
- Duty to inform the public
- Grip and sustain audiences’ attention;
- Generate revenue or goodwill
- Promote debate with different view-points
Interests during
dissemination or
communication of
evidence
- Focus is positive
results, i.e. what worked
well
- Hands-off: “A good
study speaks for its self”
- Hand-over: give report
to decision makers
- Involve stakeholders in
research processes
- Feasibility of applying new evidence:
- how to achieve the benefits in the real
world context
- How much will it cost to implement?
- How to integrated evidence with on-going
policy and practice?
- Focus is to spur individual-level actions/
awareness of the audiences
- Simplify information for non-educated
audience
- Prefer known experts as the source of
evidence
- Value evidence from first-hand face-linked
(experiential) evidence in addition to face-free
sources
Criteria for judging
strength of evidence
- Cohort studies,
Randomized studies
- Optimal
representativeness – i.e.
multi-site or multi-
country studies
-
Statistical credibility
- Long follow-up period
of cohorts
- Operations research – testing the feasibility
space eg benefits, acceptability, cost-
effectiveness, and how to implement new
interventions
- Alignment of evidence to major operational
challenges
- Timeliness for action
- Large effect size
- Indigenous evidence
- Reputation of research institution /researcher
- Aim is a “balanced” story – with “triangulation”
of different perspectives e.g. proponents,
opponents, service providers, decision-makers
- Newsworthiness of evidence
- Number of people affected
- Extent of changes from status quo
- Credibility of experts /researcher
- Verification of evidence
- Stories of affected people
- Publications in major journals and
conferences
CS: Civil Society Organizations.
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points of view.” (Media Practitioner – Television)
On the other hand, the print media practitioners
looked at the story’s impact, how topical the story was,
and the multiplier effect – how many people will read
the story and how many will it inform - as critical to
their analysis.
”There is the currency, the impact, the prominence, but
also what is called the surprise element – something
unusual, for instance a group of scientists came up with
evidence that some people appear to be resistant to HIV.
Too many people, that was the unusual surprise and you
can’t believe, that day, the newspaper almost sold-out
because of the headline. People wanted to find out more.
How is it possible that someone can be resistant to HIV?
I think those are the leading considerations for a good
story”. (Media Practitioner – Print)
Media practitioners emphasized the number of the
population affected, extraordinary evidence, and the
need to create attention – sometime in a manner that
may exaggerate the evidence. The practices of media
practitioners include extraction of information from
journals especially those that are well known – although
this approach is usually supplemented with local
experts. These findings provide opportunity for the
experts in universities to become credible sources of
information for the media. Nonetheless, there are signif-
icant challenges for these experts at universities and
similar institutions to effectively play this role. Findings
in this research revealed significant mistrust, unhelpful
attitudes, and institutional barriers for researchers to
engage with the media practitioners and advocacy agen-
cies in general.
Discussion
Findings from this study call for greater engagement of
research generating institutions such as MakCHS and
other academic institutions or agencies influential in
health policy development and policy implementation.
As detailed below, research and training institutions like
MakCHS need to develop strategic competencies to gen-
erate, assemble and disseminate evidence that address
the major feasibility constraints in implementing health
interventions and innovations if these innovations are to
become institutionalized into health policies and
practices.
This study demonstrates that PMTCT policy uptake
and continued use of implementation research to
improve programs was possible due to a shared platform
for learning and decision making across various stake-
holders in Uganda. In the early phase of the PMTCT
policy development, feasibility studies were undertaken
to provide additional evidence needed for policy scale-
up. In addition, positive program benefits were visible to
policy makers and these benefits were being used as
tools for advocacy in resource mobilization for scale-up
[31,32]. The feasibility of implementation of the
PMTCT policy was markedly enhanced by the building
of a coalition of stakeholders – inclusive of researchers,
funders, technical agencies and government officials.
Although external funds were used to implement
PMTCT programs, there was a national body assembled
that included all major stakeholders. Evidence from pol-
icy development elsewhere shows that coalitions are
useful in sharing information, resources and experiences
that enable consensus on policy making and ease the
feasibility of implementation [31,33].
Getting to a policy though important, does not guaran-
tee that policy benefits will get to the communities or
beneficiaries. For PMTCT, additional operational
research was central in guiding and improving the imple-
mentation of the policy in Uganda. Even before the
PMTCT policy was passed, implementation challenges
guided the decisions towards the policy development
processes. Findings for SMC show a similar pattern
where additional evidence was required about implemen-
tation issues before t h ep o l i c yw a sp a s s e d .I nv i e wo f
these findings, it is imperative that implementation issues
ought to be explored up-front to ensure that innovation-
type research like PMTCT and SMC move forward into
policy and programs [34]. The two case studies illustrate
the influence of external stakeholders especially willing to
finance the implementation of the programs thus boost-
ing the policy development processes.
Lessons from SMC program in Uganda suggest that
despite two years of vigorous national and international
dissemination of the SMC research evidence, the policy
process had stalled. The dissemination of evidence
around SMC prioritized global agencies relative to
national ones, and national level stakeholders were trea-
ted as secondary audiences; this might be one reason for
the slow uptake of evidence. Key to the process was the
lack of easily visible “benefits” which policymakers could
see. Although averting HIV infection is a laudable policy
goal, the benefits are invisible, and take decades to rea-
lize. In addition policymakers contested the SMC
research evidence mostly due to concerns such as politi-
cal feasibility, cultural values and discomfort with com-
plex messages. This made the research to policy process
much slower and more complicated in the case of SMC
but reflects the fact that the content of the policy and
the context influence the pace of evidence utilization in
policy development.
This study also suggests that one of the main ratio-
nales for researcher-policy maker interaction was driven
by the need to share positive findings. These findings
demand an active engagement of researchers, policy
makers and media practitioners to ensure effective
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deploying knowledge brokers, have been recommended
in the literature to bridge the gap among these key sta-
keholders [35]. Divergent view on what type of evidence
should drive policies showed that incentives, values and
rationale of different stakeholders are important in
Uganda. Our findings show that the nature of evidence
was weighed differently by stakeholders; for instance,
researchers preferred strong methodologies for policy
evidence while policymakers looked at feasibility of
implementation and also expected a broader set of evi-
dence especially for innovations like SMC. Decision
makers in Uganda needed evidence that covered all the
major dimensions of implementation feasibility like
social acceptability, cost-effectiveness, community bene-
fits and health system readiness to deliver the interven-
tion. For the media, the news value of a story, good
timing and opinions from experts – professionals,
affected persons and research scientists – were critical.
Strategies need to be instituted to overcome barriers
that media practitioners face to access the research evi-
dence and experts. Institutional incentives, support
mechanisms like training programs need to be designed
to encourage a culture conducive to active interpersonal
engagement among the three groups of stakeholders –
researchers, Policymakers and media practitioners.
Researchers need to understand the limitations of their
evidence as well as the motivation of other key stake-
holders. Researchers in Uganda and in similar contexts
also need to choose their media strategy – to inform pol-
icy makers, educate communities, or contribute to media
debate to achieve progress in the health policy processes.
Health training institutions like Makerere University Col-
lege of Health Sciences may need to cultivate coalitions
and inter-institutional linkages that increase joint and
shared learning with key institutions that influence health
decision making. In the same vein, institutions of higher
learning need to raise the public profile of key experts
and support them to undertake media relations work.
Building credibility need to go hand in hand with
expanding the engagement of these institutions in opera-
tions research that responds directly and in a timely
manner to the concerns of policy makers especially for
high stake health policies and programs.
Implications for policy and practice
The implications of these findings for Uganda (and to
the extent they resonate for other African nations) are
four-fold: 1) Although the scientists would prefer rigor
and take their time in the generation of credible evi-
dence, policy makers are more concerned about the
local relevance and “indigenization” of research evidence
– and they are also concerned with visible effects accru-
ing from applying the research evidence. 2) Where
feasible, researchers may need to build into their studies
clear measures of success in implementing their recom-
mendations and means of demonstrating the changes
attributable to their interventions. Where this is not fea-
sible researchers will need to find ways to portray future
benefits along with the feasibility of implementation.
Mathematical modeling was found to be useful in the
case of SMC [36]. 3) Media engagement would be
enhanced if researchers invited to engage with the
media were exposed to the research process earlier and
through managed interactions. Researchers can focus on
the public benefits of their work and where appropriate,
video documentaries and testimonies can be useful for
media-based communication of evidence. And finally,
(4) researchers need to prepare adequately for dissemi-
nation of controversial findings – such as providing
alternative explanations and limitations of their findings,
methods and contexts. Institutional mechanisms for
managing conflict of interests in the research processes
need to be credible and functional to mitigate the con-
troversies that could be exposed by the media’s
approach to constructing newsworthy stories. Sensa-
tional reporting of scientific results by the media need
to be born in mind when researchers are disseminating
their findings. Effective communication of the implica-
tions and limitations of the research findings are needed
to avoid erroneous extrapolations and exaggerations.
Academic institutions in Uganda and in similar con-
text elsewhere ought to frame evidence in the formats
used by media and decision makers. For media-oriented
dissemination, there is need to format the evidence to
reflect the implication of the evidence to individuals
affected, potential implications to the person, commu-
nity and population. For policy makers, the evidence
n e e d st oa d d r e s sf e a s i b i l i t yc o n s t r a i n t ss u c ha sm o n e y ,
technology and acceptability of evidence-based innova-
tions by the beneficiaries. Where funds for policy imple-
mentation are externally sourced, an assessment of
policy feasibility need to include this dimension. It is
also vital that an assessment of the techno-political ben-
e f i t sa n dr i s k so ft h ei n n o v a t i o n sa r ea d d r e s s e di ft h e
evidence-based innovations are to overcome the political
economy litmus test. Overall, this study shows that
effective translation of research might demand a “360
degree” approach to assembling the scope and nature of
evidence needed to inform policy processes. Academic
institutions also need to rethink their training of
researchers to expand competencies in the presentation
of information in multiple formats preferred by both
media and decision makers. In the same vein, the media
and decision-makers ought to develop capability to
engage with the evidence in the formats used by the
scientific communities. Provision of incentives within
institutions – media, academic and decision making
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and sharing information would be helpful. Among the
decision making institutions, an enabling environment
that supports individuals to champion evidence-based
changes with less risks to their careers would be ideal.
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